World of DTC Marketing

APRIL 12, 2021

We can’t continue to develop drugs the same way as we have done before. A blood-thinning agent, heparin, had been adulterated due to the product license holder (Baxter) procuring a toxic substance that had been illegally substituted for the genuine registered material. The question that I kept asking was why?

Generic Drugs 187

Generic Drugs Manufacturing Production Drugs 187

XTalks

FEBRUARY 8, 2021

In order to fact-check some of these misconceptions, the US Food and Drug Administration (FDA) recently hosted a webinar on biosimilar and interchangeable biological products to help healthcare professionals understand more about these treatment options. Biosimilars are the “generic” drugs of the biopharma world.

Production 78

Production Insulin Branding Generic Drugs 78

Drug Discovery World

MARCH 29, 2023

Regulatory data protection (RDP) period RDP refers to the time when generic drug makers cannot refer to an innovator drug’s data to obtain a marketing authorisation 2.

Clinical Trials 52

Clinical Trials Clinical Trials Production Medicine 52

XTalks

AUGUST 2, 2023

With each passing year, pharmaceutical companies around the globe strive to deliver cutting-edge medicines, therapies and vaccines that impact the lives of millions. Pfizer’s Top 5 Best-Selling Drugs of 2022: 1) Comirnaty Comirnaty is an mRNA-based vaccine indicated for the prevention of COVID-19. billion in 2022. billion.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

The Pharma Data

MAY 6, 2021

. US backs giving poorer countries access to COVID-19 vaccine patents, reversing stance ( Reuters ) ( STAT ) ( NYTimes ) ( Endpoints ) ( Harvard Bill of Health ) ( KEI ) ( Patent Docs ). Drugmakers say Biden misguided over vaccine patent waiver ( Reuters ) ( FT ). billion ( Reuters ) ( WSJ ). Reps.

Sales 52

Sales Vaccination Vaccine Gene Therapy 52

The Pharma Data

MAY 4, 2021

to $3.65, Primarily Reflecting Updates to Anticipated Contributions from BNT162b2 Partially Offset by Additional R&D Expenses for Vaccines to Protect Against COVID-19 as Well as Other mRNA-Based Development Programs and COVID-19 Antivirals. Raises Full-Year 2021 Guidance (3) for Revenues to a Range of $70.5 Adjusted Income (2).

Vaccination 40

Vaccination Vaccine Production Sales 40